Nebojsa Nikolic

This inventor holds 9 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc., Baxalta Gmbh. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nebojsa Nikolic. Retrieved from https://idiyas.com/inventor/nebojsa-nikolic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9

% Patents Active = 88.9

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 26(Granted Patents)

Company Filing History:

Baxter International Inc.

Takeda Pharmaceutical Company Limited

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630613 - Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use (2026-05-19),

2. 11242380 - Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use (2022-02-08),

3. 10125189 - Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use (2018-11-13),

4. 9175068 - Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use (2015-11-03),

5. 8546548 - Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use (2013-10-01),

6. 8454833 - Counter-pressure filtration of proteins (2013-06-04),

7. 8075782 - Counter-pressure filtration of proteins (2011-12-13),

8. 8075781 - Counter-pressure filtration of proteins (2011-12-13),

9. 7959809 - Counter-pressure filtration of proteins (2011-06-14),

Title: Innovations of Nebojsa Nikolic

Introduction

Nebojsa Nikolic is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of immunology, holding a total of 8 patents. His work focuses on developing advanced methods for producing immunoglobulin preparations, which are crucial for various medical applications.

Latest Patents

One of his latest patents is a method to produce a highly concentrated immunoglobulin preparation for subcutaneous use. This invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. The composition described in this patent comprises 20% or more immunoglobulin suitable for subcutaneous use, showcasing his innovative approach to enhancing treatment options.

Career Highlights

Throughout his career, Nebojsa has worked with notable companies such as Baxter International Inc. and Baxter Healthcare SA. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in medical technology.

Collaborations

Some of his coworkers include Wolfgang Teschner and Harald Arno Butterweck. Their collaboration has likely fostered an environment of innovation and creativity, leading to the development of impactful medical solutions.

Conclusion

Nebojsa Nikolic's contributions to the field of immunology through his patents and collaborations highlight his role as a key innovator in medical technology. His work continues to influence the development of effective treatments for patients worldwide.

Profile summary based on public USPTO records.